CANADA LIFE ASSURANCE Co
InsurancePosition in CTMX — CytomX Therapeutics, Inc.
CIK 1046192
WINNIPEG, A2
Position in CTMX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$58,057
+$44,706 QoQ
Shares Held
15,482
+490.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 178 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. CTMX ranks #76 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in CTMX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,057 | 15,482 | Shares | Sole | 2026-08-13 | |
| 2021-09-30 | $13,351 | 2,623 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,603 | 2,623 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $20,275 | 2,623 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,180 | 2,623 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,442 | 2,623 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $21,849 | 2,623 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $20,118 | 2,623 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||